Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide

@article{Cfaro2011PrognosticIO,
  title={Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide},
  author={Giampiero Ausili C{\'e}faro and Prof. Domenico Genovesi and Annamaria Vinciguerra and Marianna Trignani and Maria Taraborrelli and Antonietta Augurio and Roberto Buonaguidi and Renato Juan Galzio and Marta Di Nicola},
  journal={Strahlentherapie und Onkologie},
  year={2011},
  volume={187},
  pages={778-783}
}
To evaluate the influence of serum hemoglobin level prior to radiotherapy and other prognostic factors on survival in patients with high-grade gliomas. From 2001–2010, we retrospectively evaluated a total of 48 patients with malignant glioma treated with surgery and postoperative radiochemotherapy with temozolomide. A total of 37 of 48 patients received sequential temozolomide. Hemoglobin levels were assayed before radiotherapy in all patients. The Kaplan–Meier method was applied to estimate… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control

  • D Zips, S Böke, T Kroeber
  • Strahlenther Onkol
  • 2011

Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 2011;187:306–10

  • D Zips, S Böke, T Kroeber
  • Address for Correspondence Prof. Domenico…
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…